Validation of End-of-Treatment HBsAg Cut- Off Level As 200 IU/Ml in Off-Nuc Therapy Hbeag Negative Chronic Hepatitis B Patients

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalHepatology
Volume68
StatePublished - 2018

Cite this